This site is intended for healthcare professionals

Novinky z letošního nejvýznamnějšího setkání onkologů 2017

OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm)

Mark E. Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M. Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine M. Tung, Anne Armstrong, Wenting Wu, Carsten Dietrich Goessl, Sarah Runswick, Pier Franco Conte

Memorial Sloan Kettering Cancer Center, New York, NY
Seoul National University Hospital, Seoul, Korea, Republic of (South)
Medical University of Gdańsk, Gdańsk, Poland
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
Basser Center, University of Pennsylvania, Philadelphia, PA
National Hospital Organization Osaka National Hospital, Osaka, Japan
Institut Gustave Roussy, Villejuif, France
First Hospital of Jilin University, Changchun, China
Beth Israel Deaconess Medical Center and Dana-Farber Harvard Cancer Center, Boston, MA
The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
AstraZeneca, Gaithersburg, MD; AstraZeneca, Macclesfield, United Kingdom
University of Padova and Istituto Oncologico Veneto IRCCS, Padua, Italy

Meeting: 2017 ASCO Annual Meeting   Track: Oral Abstract Session Breast Cancer – Metastatic   Abstract number: LBA4   Citation: J Clin Oncol 35, 2017 (suppl; abstr LBA4)   Author(s): Mark E. Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M. Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine M. Tung, Anne Armstrong, Wenting Wu,...

Zpět

Myelodysplastic Syndrome News č. 1/2021 Czech edition

28 | 04 | 2021

Chystáme nové vydání časopisu Myelodysplastic Syndrome News.

Žijeme s roztroušenou sklerózou č. 1/2021

23 | 04 | 2021

Chystáme letošní první vydání časopisu Žijeme s roztroušenou sklerózou.

PragueONCO News č. 1/2021

19 | 04 | 2021

Již brzy vyjdou noviny PragueONCO News.




Partneři projektu